Antidepressants in the treatment of migraine headache

Current Pain and Headache Reports

Volumn 7, Issue 1, 2003, Pages 51-54

  Punay, Nestor C ^a   Couch, James R ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ANTIMIGRAINE AGENT; CITALOPRAM; DESIPRAMINE; DOXEPIN; FLUOXETINE; IMIPRAMINE; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NORTRIPTYLINE; PETHIDINE; PHENELZINE; PROPRANOLOL; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VENLAFAXINE;

APPETITE DISORDER; ASTHENIA; CLINICAL TRIAL; CLUSTER HEADACHE; CONSTIPATION; DEPRESSION; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; DRUG SELECTIVITY; EXCITEMENT; HEADACHE; HEARTBURN; HUMAN; INSOMNIA; LIVER NECROSIS; MIGRAINE; REVIEW; SEDATION; SIDE EFFECT; TACHYPHYLAXIS; TENSION HEADACHE; URINE RETENTION; XEROSTOMIA; COMORBIDITY; DRUG COMBINATION; PSYCHOLOGICAL ASPECT;

ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; COMORBIDITY; DEPRESSIVE DISORDER; DRUG THERAPY, COMBINATION; HUMANS; MIGRAINE DISORDERS; SEROTONIN UPTAKE INHIBITORS;

EID: 0037313540     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-003-0010-8     Document Type: Review

References (37)

1. Goadsby PJ: How do the currently used prophylactic agents work in migraine? Cephalalgia 1997, 17:85-92.
2. Couch JR, Hassanein RS: Amitriptyline in migraine prophylaxis. Arch Neurol 1979, 36:695-699.
3. O'Malley PG, Jackson JL, Santoro J, et al.: Antidepressant therapy for unexplained symptoms and symptom syndromes: evidence-based clinical review. J Fam Pract 1999, 48:980-990.
4. Silberstein SD: Practice parameter: evidence-based guidelines for migraine headache: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000, 55:754-762.
5. Ramadan NM, Schultz LL, Gilkey SJ: Migraine prophylactic drugs: proof of efficacy, utilization, and cost. Cephalalgia 1997, 17:73-80.
6. Holroyd KA, O'Donnell FJ, Stensland M, et al.: Management of chronic Ttension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: a randomized controlled trial. JAMA 2001, 285:2208-2215.
7. Lance JW, Anthony M: Clinical trial of a new serotonin antagonist, BC105, in the prevention of migraine. Med J Australia 1968, 1:54-55.
8. Couch JR, Ziegler DK, Hassanein RS: Amitriptyline in the prophylaxis of migraine: effectiveness and relationship of antimigraine and antidepressant effects. Neurology 1976, 26:121-127.
9. Ziegler DK, Hurwitz A, Preskorn H, et al.: Propranolol and amitriptyline in prophylaxis of migraine: pharmacokinetic and therapeutic effects. Arch Neurol 1993, 50:825-830.
10. Ziegler DK, Hurwitz A, Preskorn S, et al.: Migraine prophylaxis: a comparison of propranolol and amitriptyline. Arch Neurol 1987, 44:486-489.
11. Morland TJ, Storli OV, Mogstad TE: Doxepin in the prophylactic treatment of mixed vascular and tension headache. Headache 1979, 19:382-383.
12. Capobianco DJ, Cheshire WP, Campbell JK: An overview of the diagnosis and pharmacologic treatment of migraine. Mayo Clinic Proceedings 1996, 71:1055-1066.
13. Lance JW, Curran DA: Treatment of chronic tension headache. Lancet 1964, 1:1236-1239.
14. Redillas C, Solomon S: Prophylactic pharmacologic treatment of chronic daily headache. Headache 2000, 40:83-102.
15. Kunkel RS: Diagnosis and treatment of muscle contraction (tension-type) headaches. Med Clin North Am 1975, 3:595-603.
16. Steiner TJ, Ahmed F, Findley LJ, et al.: S-fluoxetine in the prophylaxis of migraine: a phase II double-blind, randomized, placebo-controlled study. Cephalalgia 1998, 18:283-286.
17. d'Amato CC, Pizza V, Marmolo T, et al.: Fluoxetine for migraine prophylaxis: double-blind trial. Headache 1999, 19:716-719.
18. Oguzhanoglu A, Sahiner T, Kurt T, Akalin O, Use of amitriptyline and fluoxetine in the prophylaxis of migraine and tension-type headaches. Cephalalgia 1999, 19:531-532.
19. Saper JR, Silberstein SD, Lake AE III, Winters ME: Double-blind trial of fluoxetine: chronic daily headache and migraine. Headache 1994, 34:497-502.
20. Bank JA: Comparative study of amitriptyline and fluvoxamine in migraine prophylaxis. Headache 1994, 34:476-478.
21. Manna V, Bolino F, DiCicco L: Chronic tension-type headache, mood depression, and serotonin: therapeutic effect of fluvoxamine and mianserine. Headache 1994, 34:44-49.
22. Munera P, Golstein A: Migraine and sertraline. J Am Acad Child Adolesc Psychiatry 2001, 40:1125-1126.
23. Delva NJ, Horgan SA, Hawken ER: Valproate prophylaxis for migraine induced by selective serotonin reuptake inhibitors. Headache 2000, 40:248-251.
24. Bendtsen L, Jensen R, Olesen J: A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. J Neurol Neurosurg Psychiatry 1996, 61:285-290.
25. Nutt D, Law J: Treatment of cluster headache with Mirtazapine. Headache 1999, 39:586-587.
26. Brannon GE, Rolland PD, Gary JM: Use of mirtazepine as prophylactic treatment for migraine headache. Psychosomatics 2000, 41:153-154.
27. Pinsker W: Treatment of headache with bupropion. Headache 1998, 38:58.
28. Battistella PA, Ruffilli R, Cernetti R, et al.: A placebo-controlled crossover trial using trazodone in pediatric migraine. Headache 1993, 33:36-39.
29. Pies R: Trazodone and intractable headaches. J Clin Psychiatry 1983, 44:317.
30. Brewerton TO, Murphy DL, Mueller EA, Jimerson DC: Induction of migraine-like headache by the serotonin agonist, M-chlorophenylpiperazine. Clin Pharmacol Ther 1988, 43:605-609.
31. Workman EA, Tellian SD, Short D: Trazodone induction of migraine headaches through mCPP. Am J Psychiatry 1992, 149:712.
32. Spierings EL: Hypothesis:serotonin-1C receptor activation in migraine: an alternative point of view with therapeutic implication. Headache 1991, 31:546-549.
33. Saper JR, Lake AE, Tepper SJ: Nefazodone for chronic daily headache prophylaxis: an open-label study. Headache 2001, 41:465-474.
34. Anthony M, Lance JW: Monoamine oxidase: Inhibition in the treatment of migraine. Arch Neurol 1969, 21:263-268.
35. Turkewitz LJ, Casaly JS, Dawson GA, Wirth O: Phenelzine therapy for headache patients with concomitant depression and anxiety. Headache 1992, 32:203-207.
36. Breslau N, Davis GC, Schultz LR, et al.: Migraine and major depression: a longitudinal study. Headache 1994, 7:387-393.
37. Adelman LC, Adelman JU, Von Seggern R, Mannix LK: Venlafaxine extended release for the prophylaxis of migraine and tension-type headache: a retrospective study in a clinical setting. Headache 20